Invitation to Participate in Survey on Health Messaging (Expires 28-Feb-2022)

Posted on

(Feb 11, 2022) The Office of Regional Health Operations (ORHO) in the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health (OASH), is requesting your support in an important initiative aimed at increasing community knowledge and confidence in vaccines among older African American adults with a focus on community health workers (CHWs).  We would appreciate you disseminating this survey within your organization and networks, particularly among African American community health workers aged 50 and older.
Project Overview
ORHO connects people, convenes local partners, and establishes networks to promote and advance the public health and safety of the American people. Regional Health Administrators (RHAs) within each of the 10 HHS Regional Offices serve to foster coordination and collaboration across federal departments and HHS agencies and as extensions of OASH to ensure that HHS priorities are translated and implemented at the local, state, tribal, and national levels.
Recently, HHS released the National Strategic Plan for Vaccines 2021–2025, highlighting the specific need to “reduce disparities and inequities, increase access to and use of routinely recommended vaccines across the lifespan.”  Vaccine uptake for adults has been low, and disparities persist among racial and ethnic populations. To address these disparities and encourage vaccination among adults, promotional materials on herpes zoster (shingles) and pneumococcal (pneumonia) vaccines were developed, with a specific goal of reaching African Americans aged 50 and older.
We would like to invite you to participate in a brief online survey specific to vaccine messaging and vaccine uptake. Survey responses will be anonymous and should take about 20 minutes to complete.   Your participation is important and will help ORHO to:
  • Assess the effectiveness of culturally appropriate promotional materials to increase community knowledge of and confidence in herpes zoster and pneumococcal vaccines among African American CHWs over the age of 50.
  • Assess perceptions of risk, barriers, and motivations related to general uptake of adult vaccines, including the COVID-19 vaccine.
Accessing the Survey
To access and complete the survey, please click on the following link:
This link can also be forwarded to individuals and organizations within your networks. We kindly request that the survey be completed no later than Monday February 28, 2022.
Thank you in advance for your participation. If you have any questions about this project, please contact Corstella Johnson ( If you are having technical difficulties completing the survey, please contact
Kay A. Strawder, JD, MSW
Senior Public Health Advisor – Region 9
Office of Regional Health Operations
Faafetai ma le fa’aaloalo lava,
Chantelle Eseta Matagi
State of Hawaii Department of Health
Community Liaison & Coordinator for the Immunization Branch
PH: (808)693-6427

Fentanyl summit for HI Island – Feb 22, 2022 – 10:00am-12:00noon

Posted on

Fentanyl is here – on Hawai`i Island. 

For summit registration: the virtual event will include a message from Mayor Roth and a panel of local leaders who will discuss the growing problem in our community. The panel includes representation from the police and emergency services departments; addiction and harm reduction specialists; and other important community leaders.

Please attend.

For more information:  

Fentanyl Summit Flyer

CDC panel endorses COVID-19 vaccine boosters for all adults

Posted on


A key outside advisory group to the Centers for Disease Control and Prevention (CDC) has endorsed the use of COVID-19 booster shots for all adults, a one-size-fits-all approach designed to simplify eligibility.

If CDC Director Rochelle Walensky signs off on the broader use, as expected, the extra shots will be available immediately to all adults, as long as they are six months past the final dose of a Pfizer or Moderna vaccine, or two months after a Johnson & Johnson dose.

The recommendation from the panel comes just hours after the Food and Drug Administration (FDA) authorized both Pfizer and Moderna’s booster shots for everyone over the age of 18.


Pfizer applied to the FDA earlier this month for an expansion of the emergency authorization for its booster shot to make it available to anyone 18 or older. Moderna announced just this week that it too had asked the FDA to allow its booster to be given to all adults.

Boosters for everyone has always been the Biden administration’s goal, but until now federal health authorities have stopped short of such a policy, and instead recommended boosters for only specific populations — those over age 65, anyone at high risk because of work or where they live, or those with an underlying medical condition.

The primary COVID-19 vaccination continues to provide good protection against severe disease and death, even as effectiveness against milder infection has waned. But cases have been steadily rising across the country, and authorities have said they want to stave off another winter surge.

The current recommendations, while fairly broad, have caused confusion. While people over the age of 65 are most at risk from waning vaccine immunity, fewer than 40 percent of them have received a booster, according to CDC data.

“The current guidelines, though well-intentioned and thoughtful, generate an obstacle to uptake of boosters. In pursuit of precision, they create confusion,” Nirav Shah, president of Association of State and Territorial Health Officials, told the panel.

The panel did not make a distinction in their recommendation between the two types of mRNA vaccines, despite the potential for increased risk of myocarditis — a type of heart inflammation — in young men after receiving Moderna’s vaccine.

CDC officials told the panel it’s too early to draw conclusions on the risk of myocarditis after the third dose of mRNA vaccines, because teens and younger adults haven’t yet been boosted in large enough numbers.

Several other countries have discouraged use of the Moderna vaccine in people younger than 30 because of that risk.

Water Testing for Hawai‘i Island Residents

Posted on


More Info & Consent ⇒